Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
Year: 2021
Type: article
Study design: Observational Study
Source: Leukemia Research
Institutions: Memorial Sloan Kettering Cancer Center, Temple University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W3142176715
